Interleukin Genetics (ILIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,414 | -7,898 | -6,336 | -7,058 | -5,120 |
| Depreciation Amortization | 422 | 458 | 263 | 229 | 283 |
| Accounts receivable | -20 | -48 | 506 | 57 | -542 |
| Accounts payable and accrued liabilities | 97 | -106 | -322 | 356 | 110 |
| Other Working Capital | -522 | -143 | -154 | 2,365 | 104 |
| Other Operating Activity | 894 | 1,046 | 314 | 76 | 624 |
| Operating Cash Flow | $-6,543 | $-6,691 | $-5,728 | $-3,975 | $-4,542 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -85 | -83 | -98 | -832 | -5 |
| Investing Cash Flow | $-85 | $-83 | $-98 | $-832 | $-5 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -967 | N/A | 5,000 | 0 | 1,316 |
| Common Stock Issued | 5,609 | 21 | 5,057 | 12,112 | 9 |
| Other Financing Activity | -63 | -8 | -307 | -989 | 2,719 |
| Financing Cash Flow | $4,579 | $13 | $9,750 | $11,123 | $4,044 |
| Beginning Cash Position | 4,706 | 11,467 | 7,542 | 1,225 | 1,728 |
| End Cash Position | 2,657 | 4,706 | 11,467 | 7,542 | 1,225 |
| Net Cash Flow | $-2,049 | $-6,761 | $3,925 | $6,317 | $-503 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,543 | -6,691 | -5,728 | -3,975 | -4,542 |
| Capital Expenditure | -85 | -83 | -98 | -838 | -5 |
| Free Cash Flow | -6,628 | -6,774 | -5,826 | -4,813 | -4,547 |